Mycapssa Capsule, Delayed Release
Product Images NDC 10122-550

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Mycapssa (NDC 10122-550). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chiesi Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Mycapssa 1)

FDA Label Image

Figure A (Mycapssa 2)

FDA Label Image

Figure B (Mycapssa 3)

FDA Label Image

Blister Pack (Mycapssa 4)

FDA Label Image

Blister Dose Pack (Mycapssa 5)

Blister Dose Pack (Mycapssa 5)
The text provides information about a medication called Mycapssae Ronly in the form of delayed-release capsules. Each capsule contains 20 mg of octreotide acetate. The instructions for opening and closing the medication card are provided along with the quantity of 28 capsules. The text also includes random characters and numbers, which are not readable.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.